Surgical radiofrequency tag
This article was originally published in The Gray Sheet
Executive Summary
Palm Beach Gardens, Fla.-based SurgiChip obtains clearance for SurgiChip Tag Surgical Marker system featuring "a 'smart' label with an integrated passive responder, along with a printer, an encoder and a RFID reader," FDA announces Nov. 19. The agency claims the tag likely will reduce accidental procedures. AMTSystems will co-market SurgiChip, which was exempt from 510(k) requirements. FDA's notice came four days after the agency heralded greater use of RFID technology to protect the U.S. drug supply...
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.